EPRX
Price
$5.32
Change
+$0.04 (+0.76%)
Updated
Aug 15 closing price
Capitalization
192.1M
80 days until earnings call
JWCTF
Price
$0.66
Change
+$0.01 (+1.54%)
Updated
Aug 5 closing price
Capitalization
312.24M
Interact to see
Advertisement

EPRX vs JWCTF

Header iconEPRX vs JWCTF Comparison
Open Charts EPRX vs JWCTFBanner chart's image
Eupraxia Pharmaceuticals
Price$5.32
Change+$0.04 (+0.76%)
Volume$2.22K
Capitalization192.1M
JW CAYMAN THERAPEUTICS
Price$0.66
Change+$0.01 (+1.54%)
Volume$688
Capitalization312.24M
EPRX vs JWCTF Comparison Chart in %
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. JWCTF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and JWCTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (EPRX: $5.32 vs. JWCTF: $0.66)
Brand notoriety: EPRX and JWCTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 20% vs. JWCTF: 2%
Market capitalization -- EPRX: $192.1M vs. JWCTF: $312.24M
EPRX [@Biotechnology] is valued at $192.1M. JWCTF’s [@Biotechnology] market capitalization is $312.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileJWCTF’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • JWCTF’s FA Score: 1 green, 4 red.
According to our system of comparison, JWCTF is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 3 TA indicator(s) are bullish while JWCTF’s TA Score has 2 bullish TA indicator(s).

  • EPRX’s TA Score: 3 bullish, 1 bearish.
  • JWCTF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than JWCTF.

Price Growth

EPRX (@Biotechnology) experienced а +1.20% price change this week, while JWCTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JWCTF($312M) has a higher market cap than EPRX($192M). JWCTF YTD gains are higher at: 307.531 vs. EPRX (67.921).
EPRXJWCTFEPRX / JWCTF
Capitalization192M312M62%
EBITDA-25.89MN/A-
Gain YTD67.921307.53122%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash27.5MN/A-
Total Debt52.8KN/A-
TECHNICAL ANALYSIS
Technical Analysis
EPRXJWCTF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
55%
Momentum
ODDS (%)
Bullish Trend 3 days ago
60%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 3 days ago
29%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 3 days ago
26%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 13 days ago
43%
Declines
ODDS (%)
Bearish Trend 10 days ago
77%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIREX28.150.17
+0.61%
Principal Real Estate Securities Inst
OBSIX27.25-0.02
-0.07%
Oberweis Small-Cap Opportunities Instl
DLQIX16.37-0.05
-0.30%
BNY Mellon Large Cap Equity I
IRSIX11.98-0.06
-0.50%
Voya Russell Small Cap Index Port A
CUSCX11.73-0.07
-0.59%
Cullen Small Cap Value C

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and NAGE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and NAGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+0.82%
NAGE - EPRX
33%
Poorly correlated
+3.19%
ACAD - EPRX
28%
Poorly correlated
+3.26%
MDGL - EPRX
26%
Poorly correlated
-0.41%
IOVA - EPRX
26%
Poorly correlated
+4.08%
CCCC - EPRX
25%
Poorly correlated
+4.68%
More

JWCTF and

Correlation & Price change

A.I.dvisor tells us that JWCTF and HSITF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JWCTF and HSITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JWCTF
1D Price
Change %
JWCTF100%
N/A
HSITF - JWCTF
25%
Poorly correlated
N/A
HCWB - JWCTF
12%
Poorly correlated
-5.76%
SRZN - JWCTF
8%
Poorly correlated
+2.67%
INDP - JWCTF
5%
Poorly correlated
-8.84%
EPRX - JWCTF
4%
Poorly correlated
+0.82%
More